Next Article in Journal
Cellulose Biosynthesis Inhibitors: Comparative Effect on Bean Cell Cultures
Previous Article in Journal
Synthesis and Antimicrobial Studies of Some Novel Bis-[1,3,4]thiadiazole and Bis-thiazole Pendant to Thieno[2,3-b]thiophene Moiety
Int. J. Mol. Sci. 2012, 13(3), 3671-3684; doi:10.3390/ijms13033671

Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells

2,6,*  and 1,*
1 School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China 2 Department of Chemistry and Biochemistry, The Ohio State University, Ohio 43210, USA 3 Jinan Central Hospital Affiliated to Shandong University, Jinan 250011, China 4 College of Chemistry and Environmental Sciences, Henan Normal University, Xinxiang 453002, China 5 College of Pharmacy, The University of Michigan, Michigan 48109, USA 6 College of Pharmacy, Nan Kai University, Tianjin 300071, China
* Authors to whom correspondence should be addressed.
Received: 13 February 2012 / Revised: 7 March 2012 / Accepted: 13 March 2012 / Published: 19 March 2012
View Full-Text   |   Download PDF [467 KB, uploaded 19 June 2014]   |   Browse Figures


Doxorubicin (DOX), an anthracycline antibiotic, is one of the most active anticancer chemotherapeutic agents. The clinical use of DOX, however, is limited by the dose-dependant P-glycoprotein (P-gp)-mediated resistance. Herein, a 3′-azido analogue of DOX (ADOX) was prepared from daunorubicin (DNR). ADOX exhibited potent antitumor activities in drug-sensitive (MCF-7 and K562) and drug-resistant cell lines (MCF-7/DNR, K562/DOX), respectively. The drug resistance index (DRI) values of ADOX were much lower than that of DOX. The cytotoxicity experiments of ADOX or DOX against K562/DOX, with or without P-gp inhibitor, indicated that ADOX circumvents resistance by abolishing the P-gp recognition. This conclusion was further supported by drug influx/efflux flow cytometry experiments, as well as by molecular docking of ADOX to P-gp. In vivo animal tests, ADOX exhibited higher activity and less toxicity than DOX. The current data warranted ADOX for additional pre-clinical evaluations for new drug development.
Keywords: anthracycline; Azido; multidrug resistance; ADOX; P-gp anthracycline; Azido; multidrug resistance; ADOX; P-gp
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Yu, S.; Zhang, G.; Zhang, W.; Luo, H.; Qiu, L.; Liu, Q.; Sun, D.; Wang, P.-G.; Wang, F. Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells. Int. J. Mol. Sci. 2012, 13, 3671-3684.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert